Back to compounds

COMPOUND PROFILE / PEPTIDES & ANALOGUES

LL-37.

Research draft

LL-37 is an endogenous antimicrobial host-defence peptide.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

LL-37 is an endogenous antimicrobial host-defence peptide.

CLASSIFICATIONPeptides & analogues
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

It interacts with microbes and immune signalling in context-dependent ways.

Human research

Limited route-specific clinical work exists, including an oral trial; this does not validate systemic injection.

Preclinical & other research

Extensive laboratory research includes antimicrobial and inflammatory models.

Safety & unknowns

Immune activity can be harmful as well as beneficial; systemic safety remains insufficiently characterised.

Regulatory status

No broad antimicrobial or immune-enhancement authorisation is established here.

Reported use & evidence

Research profile draft

The supplied LL-37 profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds